Jpmorgan Chase & Co »

Adial Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.7k 2.5k 1.86

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Adial Pharmaceuticals

Manchester Capital Management
Hrt Financial
BlackRock
UBS Group
Tower Research Capital
Advisor Group Holdings
Headlands Technologies
Benjamin F. Edwards & Company
Royal Bank of Canada
Morgan Stanley
Wells Fargo & Company
Qube Research & Technologies

View all funds holding Adial Pharmaceuticals